Antiplatelet agents for the treatment and prevention of atherothrombosis

Felicita Andreotti, Carlo Patrono, H Arnesen, L Badimon, C Baigent, J Collet, R De Caterina, D Gulba, K Huber, S Husted, Sd Kristensen, J Morais, F Neumann, Lh Rasmussen, A Siegbahn, P Steg, Rf Storey, F Van De Werf, F. Verheugt

Risultato della ricerca: Contributo in rivistaArticolo in rivista

174 Citazioni (Scopus)

Abstract

The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society of Cardiology (ESC) Task force and by the 8th American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines. Moreover, information on the efficacy and safety of antiplatelet drugs in the treatment and prevention of atherothrombosis is provided by collaborative meta-analyses of 287 secondary prevention trials and 6 primary prevention trials. The present document intends to provide practicing physicians with an updated instrument to guide their choice of the most suitable antiplatelet strategy for the individual patient at risk, or with different clinical manifestations, of atherothrombosis.
Lingua originaleEnglish
pagine (da-a)2922-2932
Numero di pagine11
RivistaEuropean Heart Journal
Volume32
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Coronary Artery Disease
  • Coronary Thrombosis
  • Drug Therapy, Combination
  • Humans
  • Platelet Activation
  • Platelet Aggregation Inhibitors
  • Risk Factors

Fingerprint

Entra nei temi di ricerca di 'Antiplatelet agents for the treatment and prevention of atherothrombosis'. Insieme formano una fingerprint unica.

Cita questo